Ivabradine Shows Promise as Tx for Hyperadrenergic POTS

Further study needed in other POTS subtypes In patients with hyperadrenergic postural orthostatic tachycardia syndrome (POTS), one month of treatment with ivabradine brought about significant improvements in several parameters, including heart rate, quality of life (QOL), and plasma norepinephrine (NE) levels, according to results from a recent study published in the Journal of the American

Ivabradine Shows Promise as Tx for Hyperadrenergic POTS - Physician's Weekly

PDF) Ivabradine in Postural Orthostatic Tachycardia Syndrome: A

PDF) Age-dependent modulation of xenobiotic metabolism in primary

Randomized Trial of Ivabradine in Patients With Hyperadrenergic

Ivabradine in children with postural orthostatic tachycardia

ivabradine study results · MUSINGS OF A DYSAUTONOMIAC

Article: Postural orthostatic tachycardia syndrome (POTS): a

PDF) Age-dependent modulation of xenobiotic metabolism in primary

Frontiers Chronic Treatment with Ivabradine Does Not Affect